Scholars Central

Conference abstractPublished 3 Jul 2017

Formulation, optimization and in vitro evaluation of phytonanosomes of seaweed extract as a potential antibacterial agent against human pathogenic bacteria

Authors: S M Sivakumar, Mohammad Firoz Alam, Mohammed M Safhi, Aamena Jabeen, Syeda Sanobar

Jazan University, KSA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Resistance to antibiotics is a major health problem worldwide. Various researchers around the world are trying to solve it through the discovery of new antibiotics and structurally modifying the existing antibiotics. However, complete eradication of antimicrobial resistance still remains a challenge. Bacteria may use different biochemical pathways to escape the lethal action of antibiotics viz., by changing the permeability of the outer membrane, diminishing its transport across the inner membrane or enzymatic modification. In general, resistance to multiple antibiotics in Gram-negative bacteria often starts with limited permeability of the outer membrane to many agents and antibiotics, along with more than the expression of antibiotic resistance. Seaweeds are promising potential resources of bioactive secondary metabolites in the development of many drugs. Phytochemical screening of seaweeds showed a variety of compounds such as alkaloids, flavonoids, steroids, terpenoids etc. Many earlier reports have shown the importance of seaweeds in developing antibacterial agents. Though world is progressing towards nanotechnology, its therapeutic implementation is still under study level. Seaweed extract in the form of phytonanosomes is found to be better therapeutic agent to cure bacterial infections. Thus it is a novel approach to develop a better antibacterial agent against various human pathogenic bacteria.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Drug Designing: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “S M Sivakumar”
  • BylineArticles whose byline prints “Mohammad Firoz Alam”
  • BylineArticles whose byline prints “Mohammed M Safhi”
  • BylineArticles whose byline prints “Aamena Jabeen”
  • BylineArticles whose byline prints “Syeda Sanobar”